4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid
CAS : 19741-14-1
Ref. 3D-ID20780
1g | 1.786,00 € | ||
50mg | 197,00 € | ||
100mg | 341,00 € | ||
250mg | 658,00 € | ||
500mg | 1.021,00 € |
Informations sur le produit
- 2,4-Diamino-N10-methylpteroic acidDAMPAMethotrexate impurity E hemihydrochloride hydrate
- 4-(N-(2,4-diamino-6-pteridinyl-*methyl)-N-methyl-
- 4-(N-(2,4-diamino-6-pteridinylmethyl)*-N-methyl-
- Bis(4-((2,4-Diaminopteridin-6-Ylmethyl)Methylamino)Benzoic) Acid Hydrochloride Tetrahydrate
- 4-[N-(2,4-Diamino-6-pteridinylmethyl)-N-methylamino]benzoic acid hemihydrochloride dihydrate
- 4-{[(2,4-Diaminopteridin-6-Yl)Methyl](Methyl)Amino}Benzoic Acid
4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid is a drug with low bioavailability. It is used to treat leishmaniasis, an infection caused by the parasite Leishmania. 4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid inhibits the synthesis of folic acid by blocking the enzyme dihydrofolate reductase in the bacteria. This drug also has been shown to be effective against autoimmune diseases and inflammatory bowel disease. The terminal half-life of 4-[(2,4-diamino6 pteridinyl)methyl]methylamino benzoic acid is approximately 5 hours and it can be detected in urine for up to 12 hours after administration.
Propriétés chimiques
Question d’ordre technique sur : 3D-ID20780 4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages